China Crack Tooth Syndrome Market

ID: MRFR/HC/54689-HCR
200 Pages
Nidhi Mandole
Last Updated: February 06, 2026
China Crack Tooth Syndrome Market Research Report By Diagnosis (Clinical Examination, Dye Test, X-ray, Transillumination, Radiograph, Others), By Treatment (Stabilization, Crown Restoration, Root Canal Therapy, Extraction, Others) and By Devices (Implants, Adhesives, Expendables, Others) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Diagnosis (USD Million)
      1. 4.1.1 clinical examination
      2. 4.1.2 dye test
      3. 4.1.3 X-ray
      4. 4.1.4 transillumination
      5. 4.1.5 radiograph
      6. 4.1.6 others
    2. 4.2 Chemicals and Materials, BY Types (USD Million)
      1. 4.2.1 completely fractured teeth
      2. 4.2.2 incompletely fractured teeth
    3. 4.3 Chemicals and Materials, BY Drug Class (USD Million)
      1. 4.3.1 pain killers
      2. 4.3.2 anti-biotic
      3. 4.3.3 others
    4. 4.4 Chemicals and Materials, BY Treatment (USD Million)
      1. 4.4.1 stabilization
      2. 4.4.2 crown restoration
      3. 4.4.3 root canal therapy
      4. 4.4.4 extraction
      5. 4.4.5 others
    5. 4.5 Chemicals and Materials, BY Devices (USD Million)
      1. 4.5.1 implants
      2. 4.5.2 adhesives
      3. 4.5.3 expendables
      4. 4.5.4 others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Dentsply Sirona (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Henry Schein (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 3M (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Danaher Corporation (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Coltene Holding AG (CH)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Ivoclar Vivadent AG (LI)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Kerr Corporation (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 GC Corporation (JP)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Voco GmbH (DE)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 CHINA MARKET ANALYSIS BY DIAGNOSIS
    3. 6.3 CHINA MARKET ANALYSIS BY TYPES
    4. 6.4 CHINA MARKET ANALYSIS BY DRUG CLASS
    5. 6.5 CHINA MARKET ANALYSIS BY TREATMENT
    6. 6.6 CHINA MARKET ANALYSIS BY DEVICES
    7. 6.7 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    10. 6.10 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    12. 6.12 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    13. 6.13 CHEMICALS AND MATERIALS, BY DIAGNOSIS, 2024 (% SHARE)
    14. 6.14 CHEMICALS AND MATERIALS, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
    15. 6.15 CHEMICALS AND MATERIALS, BY TYPES, 2024 (% SHARE)
    16. 6.16 CHEMICALS AND MATERIALS, BY TYPES, 2024 TO 2035 (USD Million)
    17. 6.17 CHEMICALS AND MATERIALS, BY DRUG CLASS, 2024 (% SHARE)
    18. 6.18 CHEMICALS AND MATERIALS, BY DRUG CLASS, 2024 TO 2035 (USD Million)
    19. 6.19 CHEMICALS AND MATERIALS, BY TREATMENT, 2024 (% SHARE)
    20. 6.20 CHEMICALS AND MATERIALS, BY TREATMENT, 2024 TO 2035 (USD Million)
    21. 6.21 CHEMICALS AND MATERIALS, BY DEVICES, 2024 (% SHARE)
    22. 6.22 CHEMICALS AND MATERIALS, BY DEVICES, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DIAGNOSIS, 2025-2035 (USD Million)
      2. 7.2.2 BY TYPES, 2025-2035 (USD Million)
      3. 7.2.3 BY DRUG CLASS, 2025-2035 (USD Million)
      4. 7.2.4 BY TREATMENT, 2025-2035 (USD Million)
      5. 7.2.5 BY DEVICES, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

China Chemicals and Materials Market Segmentation

Chemicals and Materials By Diagnosis (USD Million, 2025-2035)

  • clinical examination
  • dye test
  • X-ray
  • transillumination
  • radiograph
  • others

Chemicals and Materials By Types (USD Million, 2025-2035)

  • completely fractured teeth
  • incompletely fractured teeth

Chemicals and Materials By Drug Class (USD Million, 2025-2035)

  • pain killers
  • anti-biotic
  • others

Chemicals and Materials By Treatment (USD Million, 2025-2035)

  • stabilization
  • crown restoration
  • root canal therapy
  • extraction
  • others

Chemicals and Materials By Devices (USD Million, 2025-2035)

  • implants
  • adhesives
  • expendables
  • others